# Report for Representative Clark (MA)

## Top Industry Donors
| Industry Description | Donation Amount |
|----------------------|-----------------|
| Pharmaceuticals/Health Products | $140,750.00 |
| Securities & Investment | $122,275.00 |
| Lobbyists | $116,435.00 |
| Misc Issues | $112,900.00 |
| Insurance | $97,690.00 |
| Real Estate | $94,837.00 |
| Retired | $87,805.00 |
| Lawyers/Law Firms | $83,395.00 |
| Health Professionals | $78,355.00 |
| Pro-Israel | $75,183.00 |

## Roll Call Votes Related To Top Industry Donors
| Bill Name | Bill DateTime | Roll Call ID | Year | Question | Vote | Related Industries |
|-----------|---------------|--------------|------|----------|------|--------------------|
| 118-hr-1398-bill | [2024-09-11 04:00:00](../bills/118-hr-1398/2024-09-11T04:00:00Z-118-hr-1398-bill-summary.md) | 412 | 2024 | On Motion to Recommit | Yea | Lawyers/Law Firms |
| 118-hr-1398-bill | [2024-09-11 04:00:00](../bills/118-hr-1398/2024-09-11T04:00:00Z-118-hr-1398-bill-summary.md) | 413 | 2024 | On Passage | Nay | Lawyers/Law Firms |
| 118-hr-4790-bill | [2024-09-19 04:00:00](../bills/118-hr-4790/2024-09-19T04:00:00Z-118-hr-4790-bill-summary.md) | 434 | 2024 | On Motion to Recommit | Yea | Securities & Investment |
| 118-hr-4790-bill | [2024-09-19 04:00:00](../bills/118-hr-4790/2024-09-19T04:00:00Z-118-hr-4790-bill-summary.md) | 435 | 2024 | On Passage | Nay | Securities & Investment |
| 118-hr-5339-bill | [2024-09-18 04:00:00](../bills/118-hr-5339/2024-09-18T04:00:00Z-118-hr-5339-bill-summary.md) | 426 | 2024 | On Motion to Recommit | Yea | Securities & Investment |
| 118-hr-5339-bill | [2024-09-18 04:00:00](../bills/118-hr-5339/2024-09-18T04:00:00Z-118-hr-5339-bill-summary.md) | 427 | 2024 | On Passage | Nay | Securities & Investment |
| 118-hr-7213-bill | [2024-07-30 04:00:00](../bills/118-hr-7213/2024-07-30T04:00:00Z-118-hr-7213-bill-summary.md) | 424 | 2024 | On Motion to Suspend the Rules and Pass, as Amended | Yea | Health Professionals, Pharmaceuticals/Health Products |
| 118-hr-8333-bill | [2024-09-09 04:00:00](../bills/118-hr-8333/2024-09-09T04:00:00Z-118-hr-8333-bill-summary.md) | 402 | 2024 | On Motion to Suspend the Rules and Pass, as Amended | Nay | Pharmaceuticals/Health Products |
| 118-hr-9747-bill | [2024-09-25 04:00:00](../bills/118-hr-9747/2024-09-25T04:00:00Z-118-hr-9747-bill-summary.md) | 450 | 2024 | On Motion to Suspend the Rules and Pass | Yea | Health Professionals, Pharmaceuticals/Health Products |
| 118-hres-1455-bill | [2024-09-17 04:00:00](../bills/118-hres-1455/2024-09-17T04:00:00Z-118-hres-1455-bill-summary.md) | 420 | 2024 | On Ordering the Previous Question | Nay | Securities & Investment |
| 118-hres-1455-bill | [2024-09-17 04:00:00](../bills/118-hres-1455/2024-09-17T04:00:00Z-118-hres-1455-bill-summary.md) | 421 | 2024 | On Agreeing to the Resolution | Nay | Securities & Investment |
| 118-s-1146-bill | [2023-10-30 04:00:00](../bills/118-s-1146/2023-10-30T04:00:00Z-118-s-1146-bill-summary.md) | 422 | 2024 | On Motion to Suspend the Rules and Pass, as Amended | Yea | Lawyers/Law Firms |
